Ticker: APLS

Company: Apellis Pharmaceuticals, Inc.

Person: Caroline Baumal, officer

Transaction date: Jan. 20, 2026

Reporting date: Jan. 21, 2026

Average share price: 19.792900000000003

Sold 1882.0 shares for 37250.24